A new method for assessing drug causation provided agreement with experts' judgment

被引:48
作者
Arimone, Y
Bégaud, B
Miremont-Salamé, G
Fourrier-Réglat, A
Molimard, M
Moore, N
Haramburu, F
机构
[1] INSERM, U657, F-33076 Bordeaux, France
[2] Univ Victor Segalen Bordeaux 2, Dept Pharmacol, F-33076 Bordeaux, France
[3] CHU Bordeaux, Hop Pellegrin, Ctr Pharmacovigilance, F-33076 Bordeaux, France
关键词
drug safety; epidemiology; causality; adverse effects; consensus; methods;
D O I
10.1016/j.jclinepi.2005.08.012
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background and Objective: The many methods proposed for causality assessment of adverse drug reaction (ADR) generally rely on algorithms. They have no clear relationship to probabilities, however, a situation we attempted to improve. Study Design and Setting: Thirty ADR cases corresponding to 32 suspect drugs were randomly selected from the French pharmacovigilance database. The statistical weighting was per-formed by using a multilinear regression with logit(p) as the dependent variable and seven judgment criteria as independent variables. The best model (i.e., giving the best correlation with the gold standard) was retained for the new causality assessment method. Results: The weights [logit(p)] for the 21 choices, on average three for each of the seven criteria, ranged from -3.95 to 0.86, secondarily rounded to multiples of 0.5. The correlation between the probability obtained from the final method and the gold standard was quite good (R-2 = .92). Conclusion: This method based on the rational weighting of seven causality criteria is straightforward to use and provides very good agreement with experts' judgment. Moreover, unlike most classical algorithms, it respects one basic rule of probabilities-namely, a symmetrical probability distribution for drug causation around the .5 neutral position (maximum uncertainty). (C) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:308 / 314
页数:7
相关论文
共 22 条
[1]  
AURICHE M, 1985, THERAPIE, V40, P301
[2]  
BEGAUD B, 1985, THERAPIE, V40, P111
[3]  
Begaud B., 2000, Dictionary of Pharmacoepidemiology
[4]   CAUSALITY ASSESSMENT OF ADVERSE REACTIONS TO DRUGS .2. AN ORIGINAL MODEL FOR VALIDATION OF DRUG CAUSALITY ASSESSMENT METHODS - CASE-REPORTS WITH POSITIVE RECHALLENGE [J].
BENICHOU, C ;
DANAN, G ;
FLAHAULT, A .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1993, 46 (11) :1331-1336
[5]  
BLANC S, 1979, CLIN PHARMACOL THER, V25, P493
[6]   CAUSALITY ASSESSMENT OF ADVERSE REACTIONS TO DRUGS .1. A NOVEL METHOD BASED ON THE CONCLUSIONS OF INTERNATIONAL CONSENSUS MEETINGS - APPLICATION TO DRUG-INDUCED LIVER INJURIES [J].
DANAN, G ;
BENICHOU, C .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1993, 46 (11) :1323-1330
[7]  
DANGOUMAU J, 1978, THERAPIE, V33, P373
[8]   HARMONIZATION IN PHARMACOVIGILANCE [J].
EDWARDS, IR ;
BIRIELL, C .
DRUG SAFETY, 1994, 10 (02) :93-102
[9]  
Emanueli A, 1980, Agents Actions Suppl, V7, P318
[10]  
FEINSTEIN AR, 1974, CLIN PHARMACOL THER, V16, P846